Divergent lncRNA MYMLR regulates MYC by eliciting DNA looping and promoter-enhancer interaction.


Journal

The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664

Informations de publication

Date de publication:
02 09 2019
Historique:
received: 17 10 2017
revised: 13 06 2019
accepted: 21 06 2019
pubmed: 31 7 2019
medline: 24 12 2019
entrez: 31 7 2019
Statut: ppublish

Résumé

Long non-coding RNAs (lncRNAs) function in a wide range of processes by diverse mechanisms, though their roles in regulation of oncogenes and/or tumor suppressors remain rather elusive. We performed a global search for lncRNAs affecting MYC activity using a systems biology-based approach with a K supercomputer and the GIMLET algorism based on local distance correlations. Consequently, MYMLR was identified and experimentally shown to maintain MYC transcriptional activity and cell cycle progression despite the low levels of expression. A proteomic search for MYMLR-binding proteins identified PCBP2, while it was also found that MYMLR places a 557-kb upstream enhancer region in the proximity of the MYC promoter in cooperation with PCBP2. These findings implicate a crucial role for MYMLR in regulation of the archetypical oncogene MYC and warrant future studies regarding the involvement of low copy number lncRNAs in regulation of other crucial oncogenes and tumor suppressor genes.

Identifiants

pubmed: 31361039
doi: 10.15252/embj.201798441
pmc: PMC6717891
doi:

Substances chimiques

MYC protein, human 0
PCBP2 protein, human 0
Proto-Oncogene Proteins c-myc 0
RNA, Long Noncoding 0
RNA-Binding Proteins 0
long noncoding RNA CASC11, human 0

Banques de données

GEO
['GSE103085']
GENBANK
['MH782193']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e98441

Subventions

Organisme : Ministry of Education, Culture, Sports, Science and Technology (MEXT)
ID : 15H05910
Pays : International
Organisme : MEXT|Japan Society for the Promotion of Science (JSPS)
ID : 16H02468
Pays : International
Organisme : MEXT|Japan Society for the Promotion of Science (JSPS)
ID : 16K19050
Pays : International
Organisme : Princess Takamatsu Cancer Research Fund
Pays : International
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : 18ck0106363h0002
Pays : International

Informations de copyright

© 2019 The Authors.

Références

Nat Rev Genet. 2014 Jan;15(1):7-21
pubmed: 24296535
Nat Genet. 2007 May;39(5):638-44
pubmed: 17401364
EMBO J. 2019 Sep 2;38(17):e98441
pubmed: 31361039
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Biochem Biophys Res Commun. 2009 Mar 13;380(3):431-6
pubmed: 19284986
Genome Biol. 2013;14(9):R104
pubmed: 24070194
Nat Rev Cancer. 2015 Oct;15(10):593-607
pubmed: 26383138
Cancer Sci. 2017 Jul;108(7):1394-1404
pubmed: 28474808
Cell. 2007 Jun 29;129(7):1311-23
pubmed: 17604720
Nature. 2011 Apr 7;472(7341):120-4
pubmed: 21423168
Jpn J Clin Oncol. 1993 Feb;23(1):14-9
pubmed: 8384671
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Cancer Res. 2007 Oct 15;67(20):9762-70
pubmed: 17942906
Cancer Cell. 2014 Nov 10;26(5):722-37
pubmed: 25517750
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):8866-71
pubmed: 18579786
Nat Genet. 2007 Aug;39(8):984-8
pubmed: 17618284
Neoplasia. 2014 Nov 20;16(11):900-8
pubmed: 25425964
Nature. 2007 Jun 28;447(7148):1087-93
pubmed: 17529967
Nat Rev Genet. 2014 Apr;15(4):272-86
pubmed: 24614317
Nature. 2014 Aug 7;512(7512):82-6
pubmed: 25043044
Annu Rev Biochem. 2012;81:145-66
pubmed: 22663078
Cell. 2012 Mar 30;149(1):22-35
pubmed: 22464321
Nucleic Acids Res. 2017 May 19;45(9):5458-5469
pubmed: 28160600
Carcinogenesis. 2015 Dec;36(12):1464-73
pubmed: 26483346
Cell Res. 2014 May;24(5):513-31
pubmed: 24662484
Nature. 1983 Nov 10-16;306(5939):194-6
pubmed: 6646201
Science. 2002 Feb 15;295(5558):1306-11
pubmed: 11847345
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959

Auteurs

Taisuke Kajino (T)

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Division of Molecular Diagnostics, Aichi Cancer Center Research Institute, Nagoya, Japan.

Teppei Shimamura (T)

Division of Systems Biology, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Shuyi Gong (S)

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Kiyoshi Yanagisawa (K)

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Lisa Ida (L)

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Masahiro Nakatochi (M)

Statistical Analysis Section, Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.

Sebastian Griesing (S)

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yukako Shimada (Y)

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Division of Molecular Diagnostics, Aichi Cancer Center Research Institute, Nagoya, Japan.

Keiko Kano (K)

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Motoshi Suzuki (M)

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Satoru Miyano (S)

Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.

Takashi Takahashi (T)

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Aichi Cancer Center, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH